Gynaecological Care for Transgender People in France in 2024.

Recruiting

• Conditions: Transgender Management Care
• Interventions: Other: Questionnaire

• Registration Number: NCT06357130
• Lead Sponsor: University Hospital, Bordeaux

Brief Summary

To date, the transgender population, still poorly characterized, tends to increase. The impact of gender-affirming hormone therapy (GAHT) in this population remains poorly understood, and few data are published on the gynecological repercussions of such therapy. A recent literature review by a French team suggests gynecological follow-up procedures for transgender people.

Detailed Description

The hypothesis of this study is that transgender population in France does not have appropriate gynecological care, and the study would like to find out, directly from the people concerned, the current state of gynecological care for transgender people in France. To do this, ths study plan to send out a questionnaire to transgender people (via healthcare networks and also transgender associations) to ask them about their actual gynecological care and their knowledge of recommended gynecological care.

The aim is to set up a descriptive, declarative study based on a questionnaire created specifically for this work.

This project will use a questionnaire for transwomen people and another one for transmen people. Transgender people will be approached via Trans associations and healthcare networks. An online link to the questionnaire will be sent to trans associations and healthcare networks for distribution to the target population thanks to a flyer.

Study Timeline

• Study First Submitted: 2024-04-04
• Study First Submitted QC: 2024-04-04
• Study First Posted: 2024-04-10
• Study Start: 2024-06-03
• Status Verified: 2024-12
• Last Update Submitted: 2024-12-19
• Last Update Posted: 2024-12-20
• Primary Completion: 2026-06
• Study Completion: 2026-06

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 500

Inclusion Criteria

• French-speaking transgender person (transgender women or transgender men)
• age ≥18 years

Exclusion Criteria

• age <18 years

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Transgender	Questionnaire	Transgender population in France, male to female and female to male.

Primary Outcome Measures

Name	Time	Method
Percentage of people aware of gynaecological recommendations.	24 months after inclusion day	Percentage of transgender people who know regular gynaecological recommendations in France, thanks to a homemade questionnaire

Secondary Outcome Measures

Name	Time	Method
Percentage of people aware of gynaecological repercussions of masculinizing hormone treatment in transgender male population	24 months after inclusion day	Overview of our knowledge of the gynaecological repercussions of masculinizing hormone treatment in the transgender male population, thanks to a homemade questionnaire.
Percentage of people aware of cancer risks	24 months after inclusion day	Overview of organized screening for gynaecological cancers and prostate cancer in the transgender population, thanks to a homemade questionnaire
Percentage of people aware of contraception in transgender male population	24 months after inclusion day	Overview of knowledge about contraception in the transgender male population,thanks to a homemade questionnaire.
Percentage of people aware of fertility and the impact of hormone treatments	24 months after inclusion day	Overview of knowledge about fertility and the impact of hormone treatments in the transgender population, thanks to a homemade questionnaire.

Trial Locations

Locations (1)

Hopital Haut-Lévêque; 🇫🇷 Pessac, France